The Current State of Breast Cancer Genetics in Populations of African Ancestry
Abstract
:1. Introduction
2. Materials and Methods
2.1. Search Strategy and Eligibility Criteria
2.2. Study Selection
3. Results
3.1. Breast Cancer Genetics
3.2. Breast Cancer Genetic Studies in African and African Ancestry Populations
3.3. Breast Cancer Genomic Studies in African and African Ancestry Populations
4. Discussion and Conclusions
Supplementary Materials
Author Contributions
Funding
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Bray, F.; Laversanne, M.; Sung, H.; Ferlay, J.; Siegel, R.L.; Soerjomataram, I.; Jemal, A. Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA A Cancer J. Clin. 2024, 74, 229–263. [Google Scholar] [CrossRef] [PubMed]
- Harbeck, N.; Penault-Llorca, F.; Cortes, J.; Gnant, M.; Houssami, N.; Poortmans, P.; Ruddy, K.; Tsang, J.; Cardoso, F. Breast Cancer. Nat. Rev. Dis. Primers 2019, 5, 66. [Google Scholar] [CrossRef] [PubMed]
- Giaquinto, A.N.; Miller, K.D.; Tossas, K.Y.; Winn, R.A.; Jemal, A.; Siegel, R.L. Cancer Statistics for African American/Black People 2022. CA A Cancer J. Clin. 2022, 72, 202–229. [Google Scholar] [CrossRef] [PubMed]
- Chen, T.; Kharazmi, E.; Fallah, M. Race and Ethnicity–Adjusted Age Recommendation for Initiating Breast Cancer Screening. JAMA Netw. Open 2023, 6, e238893. [Google Scholar] [CrossRef] [PubMed]
- INCA. Câncer de Mama: Vamos Falar Sobre Isso? Available online: https://www.inca.gov.br/publicacoes/cartilhas/cancer-de-mama-vamos-falar-sobre-isso (accessed on 20 March 2024).
- Migowski, A.; Dias, M.B.K.; Nadanovsky, P.; Silva, G.A.E.; Sant’Ana, D.R.; Stein, A.T. Diretrizes para detecção precoce do câncer de mama no Brasil. III—Desafios à implementação. Cad. Saúde Pública 2018, 34, e00046317. [Google Scholar] [CrossRef]
- Migowski, A.; Corrêa, F.d.M. Recomendações para detecção precoce de câncer durante a pandemia de covid-19 em 2021. Rev. De APS 2020, 23, 235–240. [Google Scholar]
- Hercules, S.M.; Alnajar, M.; Chen, C.; Mladjenovic, S.M.; Shipeolu, B.A.; Perkovic, O.; Pond, G.R.; Mbuagbaw, L.; Blenman, K.R.; Daniel, J.M. Triple-Negative Breast Cancer Prevalence in Africa: A Systematic Review and Meta-Analysis. BMJ Open 2022, 12, e055735. [Google Scholar] [CrossRef]
- Liao, L. Inequality in Breast Cancer: Global Statistics from 2022 to 2050. Breast 2024, 79, 103851. [Google Scholar] [CrossRef] [PubMed]
- Azubuike, S.O.; Muirhead, C.; Hayes, L.; McNally, R. Rising Global Burden of Breast Cancer: The Case of Sub-Saharan Africa (with Emphasis on Nigeria) and Implications for Regional Development: A Review. World J. Surg. Onc. 2018, 16, 63. [Google Scholar] [CrossRef]
- Adeoye, P.A. Epidemiology of Breast Cancer in Sub-Saharan Africa. In Breast Cancer Updates; IntechOpen: London, UK, 2023; ISBN 978-1-80355-931-5. [Google Scholar] [CrossRef]
- Hamdi, Y.; Abdeljaoued-Tej, I.; Zatchi, A.A.; Abdelhak, S.; Boubaker, S.; Brown, J.S.; Benkahla, A. Cancer in Africa: The Untold Story. Front. Oncol. 2021, 11, 650117. [Google Scholar] [CrossRef] [PubMed]
- Chen, S.; Cao, Z.; Prettner, K.; Kuhn, M.; Yang, J.; Jiao, L.; Wang, Z.; Li, W.; Geldsetzer, P.; Bärnighausen, T.; et al. Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050. JAMA Oncol. 2023, 9, 465–472. [Google Scholar] [CrossRef] [PubMed]
- Blumen, H.; Fitch, K.; Polkus, V. Comparison of Treatment Costs for Breast Cancer, by Tumor Stage and Type of Service. Am. Health Drug Benefits 2016, 9, 23–32. [Google Scholar]
- Sun, L.; Legood, R.; dos-Santos-Silva, I.; Gaiha, S.M.; Sadique, Z. Global Treatment Costs of Breast Cancer by Stage: A Systematic Review. PLoS ONE 2018, 13, e0207993. [Google Scholar] [CrossRef] [PubMed]
- Dobbin, E.A.F.; Medeiros, J.A.G.; Costa, M.S.C.R.; Rodrigues, J.C.G.; Guerreiro, J.F.; Kroll, J.E.; Souza, S.J.D.; de Assumpção, P.P.; Ribeiro-dos-Santos, Â.; Santos, S.E.B.D.; et al. Identification of Variants (Rs11571707, Rs144848, and Rs11571769) in the BRCA2 Gene Associated with Hereditary Breast Cancer in Indigenous Populations of the Brazilian Amazon. Genes 2021, 12, 142. [Google Scholar] [CrossRef]
- Gaceb, H.; Cherbal, F.; Bakour, R.; Ould-Rouis, A.; Mahfouf, H. Clinicopathological and Molecular Study of Triple-Negative Breast Cancer in Algerian Patients. Pathol. Oncol. Res. 2018, 24, 297–308. [Google Scholar] [CrossRef] [PubMed]
- Silva, F.C.; Lisboa, B.C.; Figueiredo, M.C.; Torrezan, G.T.; Santos, É.M.; Krepischi, A.C.; Rossi, B.M.; Achatz, M.I.; Carraro, D.M. Hereditary Breast and Ovarian Cancer: Assessment of Point Mutations and Copy Number Variations in Brazilian Patients. BMC Med. Genet. 2014, 15, 55. [Google Scholar] [CrossRef] [PubMed]
- Van der Merwe, N.C.; Combrink, H.M.; Ntaita, K.S.; Oosthuizen, J. Prevalence of Clinically Relevant Germline BRCA Variants in a Large Unselected South African Breast and Ovarian Cancer Cohort: A Public Sector Experience. Front. Genet. 2022, 13, 834265. [Google Scholar] [CrossRef]
- Bertwistle, D.; Swift, S.; Marston, N.J.; Jackson, L.E.; Crossland, S.; Crompton, M.R.; Marshall, C.J.; Ashworth, A. Nuclear Location and Cell Cycle Regulation of the BRCA2 Protein. Cancer Res. 1997, 57, 5485–5488. [Google Scholar] [PubMed]
- Chen, Z.; Guo, X.; Long, J.; Ping, J.; Li, B.; Fadden, M.K.; Ahearn, T.U.; Stram, D.O.; Shu, X.-O.; Jia, G.; et al. Discovery of Structural Deletions in Breast Cancer Predisposition Genes Using Whole Genome Sequencing Data from >2000 Women of African-Ancestry. Hum. Genet. 2021, 140, 1449–1457. [Google Scholar] [CrossRef]
- Henouda, S.; Bensalem, A.; Reggad, R.; Serrar, N.; Rouabah, L.; Pujol, P. Contribution of BRCA1 and BRCA2 Germline Mutations to Early Algerian Breast Cancer. Dis. Markers 2016, 2016, 7869095. [Google Scholar] [CrossRef] [PubMed]
- Abbad, A.; Baba, H.; Dehbi, H.; Elmessaoudi-Idrissi, M.; Elyazghi, Z.; Abidi, O.; Radouani, F. Genetics of Breast Cancer in African Populations: A Literature Review. Glob. Health Epidemiol. 2018, 3, e8. [Google Scholar] [CrossRef] [PubMed]
- Hayat, M.; Chen, W.C.; Brandenburg, J.-T.; Babb de Villiers, C.; Ramsay, M.; Mathew, C.G. Genetic Susceptibility to Breast Cancer in Sub-Saharan African Populations. JCO Glob. Oncol. 2021, 7, GO.21.00089. [Google Scholar] [CrossRef] [PubMed]
- da Costa Vieira, R.A.; Sant’Anna, D.; Laus, A.C.; Bacchi, C.E.; Silva, R.J.C.; de Oliveira-Junior, I.; da Silva, V.D.; Pereira, R.; Reis, R.M. Genetic Ancestry of 1127 Brazilian Breast Cancer Patients and Its Correlation With Molecular Subtype and Geographic Region. Clin. Breast Cancer 2023, 23, 527–537. [Google Scholar] [CrossRef] [PubMed]
- Jiagge, E.; Chitale, D.; Newman, L.A. Triple-Negative Breast Cancer, Stem Cells, and African Ancestry. Am. J. Pathol. 2018, 188, 271–279. [Google Scholar] [CrossRef] [PubMed]
- Omilian, A.R.; Wei, L.; Hong, C.-C.; Bandera, E.V.; Liu, S.; Khoury, T.; Ambrosone, C.B.; Yao, S. Somatic Mutations of Triple-Negative Breast Cancer: A Comparison between Black and White Women. Breast Cancer Res. Treat. 2020, 182, 503–509. [Google Scholar] [CrossRef]
- Palmer, J.R.; Ruiz-Narvaez, E.A.; Rotimi, C.N.; Cupples, L.A.; Cozier, Y.C.; Adams-Campbell, L.L.; Rosenberg, L. Genetic Susceptibility Loci for Subtypes of Breast Cancer in an African American Population. Cancer Epidemiol. Biomark. Prev. 2013, 22, 127–134. [Google Scholar] [CrossRef] [PubMed]
- Kenemans, P.; Verstraeten, R.A.; Verheijen, R.H.M. Oncogenic Pathways in Hereditary and Sporadic Breast Cancer. Maturitas 2004, 49, 34–43. [Google Scholar] [CrossRef]
- Van Der Groep, P. Distinction between Hereditary and Sporadic Breast Cancer on the Basis of Clinicopathological Data. J. Clin. Pathol. 2006, 59, 611–617. [Google Scholar] [CrossRef] [PubMed]
- Hassanpour, S.H.; Dehghani, M. Review of Cancer from Perspective of Molecular. J. Cancer Res. Pract. 2017, 4, 127–129. [Google Scholar] [CrossRef]
- Arzanova, E.; Mayrovitz, H.N. The Epidemiology of Breast Cancer. In Breast Cancer; Mayrovitz, H.N., Ed.; Exon Publications: Brisbane, Australia, 2022; ISBN 978-0-645-33203-2. [Google Scholar]
- Orrantia-Borunda, E.; Anchondo-Nuñez, P.; Acuña-Aguilar, L.E.; Gómez-Valles, F.O.; Ramírez-Valdespino, C.A. Subtypes of Breast Cancer. In Breast Cancer; Mayrovitz, H.N., Ed.; Exon Publications: Brisbane, Australia, 2022; ISBN 978-0-645-33203-2. [Google Scholar]
- Zhang, X. Molecular Classification of Breast Cancer: Relevance and Challenges. Arch. Pathol. Lab. Med. 2022, 147, 46–51. [Google Scholar] [CrossRef] [PubMed]
- Goldhirsch, A.; Wood, W.C.; Coates, A.S.; Gelber, R.D.; Thürlimann, B.; Senn, H.-J. Strategies for Subtypes—Dealing with the Diversity of Breast Cancer: Highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann. Oncol. 2011, 22, 1736–1747. [Google Scholar] [CrossRef] [PubMed]
- Obidiro, O.; Battogtokh, G.; Akala, E.O. Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook. Pharmaceutics 2023, 15, 1796. [Google Scholar] [CrossRef] [PubMed]
- Martini, R.; Delpe, P.; Chu, T.R.; Arora, K.; Lord, B.; Verma, A.; Bedi, D.; Karanam, B.; Elhussin, I.; Chen, Y.; et al. African Ancestry-Associated Gene Expression Profiles in Triple-Negative Breast Cancer Underlie Altered Tumor Biology and Clinical Outcome in Women of African Descent. Cancer Discov. 2022, 12, 2530–2551. [Google Scholar] [CrossRef] [PubMed]
- Huo, D.; Feng, Y.; Haddad, S.; Zheng, Y.; Yao, S.; Han, Y.-J.; Ogundiran, T.O.; Adebamowo, C.; Ojengbede, O.; Falusi, A.G.; et al. Genome-Wide Association Studies in Women of African Ancestry Identified 3q26.21 as a Novel Susceptibility Locus for Oestrogen Receptor Negative Breast Cancer. Hum. Mol. Genet. 2016, 25, 4835–4846. [Google Scholar] [CrossRef]
- Mavaddat, N.; Antoniou, A.C.; Easton, D.F.; Garcia-Closas, M. Genetic Susceptibility to Breast Cancer. Mol. Oncol. 2010, 4, 174–191. [Google Scholar] [CrossRef]
- Hamdi, Y.; Soucy, P.; Adoue, V.; Michailidou, K.; Canisius, S.; Lemaçon, A.; Droit, A.; Andrulis, I.L.; Anton-Culver, H.; Arndt, V.; et al. Association of Breast Cancer Risk with Genetic Variants Showing Differential Allelic Expression: Identification of a Novel Breast Cancer Susceptibility Locus at 4q21. Oncotarget 2016, 7, 80140–80163. [Google Scholar] [CrossRef] [PubMed]
- Lin, X.; Guo, L.; Lin, X.; Wang, Y.; Zhang, G. Expression and Prognosis Analysis of Mitochondrial Ribosomal Protein Family in Breast Cancer. Sci. Rep. 2022, 12, 10658. [Google Scholar] [CrossRef] [PubMed]
- Pelttari, L.M.; Kinnunen, L.; Kiiski, J.I.; Khan, S.; Blomqvist, C.; Aittomäki, K.; Nevanlinna, H. Screening of HELQ in Breast and Ovarian Cancer Families. Fam. Cancer 2016, 15, 19–23. [Google Scholar] [CrossRef] [PubMed]
- Tang, W.; Zhang, F.; Byun, J.S.; Dorsey, T.H.; Yfantis, H.G.; Ajao, A.; Liu, H.; Pichardo, M.S.; Pichardo, C.M.; Harris, A.R.; et al. Population-Specific Mutation Patterns in Breast Tumors from African American, European American, and Kenyan Patients. Cancer Res. Commun. 2023, 3, 2244–2255. [Google Scholar] [CrossRef]
- Aldrighetti, C.M.; Niemierko, A.; Van Allen, E.; Willers, H.; Kamran, S.C. Racial and Ethnic Disparities Among Participants in Precision Oncology Clinical Studies. JAMA Netw. Open 2021, 4, e2133205. [Google Scholar] [CrossRef] [PubMed]
- Stacey, S.N.; Manolescu, A.; Sulem, P.; Rafnar, T.; Gudmundsson, J.; Gudjonsson, S.A.; Masson, G.; Jakobsdottir, M.; Thorlacius, S.; Helgason, A.; et al. Common Variants on Chromosomes 2q35 and 16q12 Confer Susceptibility to Estrogen Receptor–Positive Breast Cancer. Nat. Genet. 2007, 39, 865–869. [Google Scholar] [CrossRef] [PubMed]
- Adhikari, K.; Mendoza-Revilla, J.; Chacón-Duque, J.C.; Fuentes-Guajardo, M.; Ruiz-Linares, A. Admixture in Latin America. Curr. Opin. Genet. Dev. 2016, 41, 106–114. [Google Scholar] [CrossRef]
- Salzano, F.M.; Bortolini, M.C. The Evolution and Genetics of Latin American Populations, 1st ed.; Cambridge University Press: Cambridge, UK, 2001; ISBN 978-0-521-65275-9. [Google Scholar]
- Salzano, F.M.; Sans, M. Interethnic Admixture and the Evolution of Latin American Populations. Genet. Mol. Biol. 2014, 37, 151–170. [Google Scholar] [CrossRef] [PubMed]
- Zavala, V.A.; Serrano-Gomez, S.J.; Dutil, J.; Fejerman, L. Genetic Epidemiology of Breast Cancer in Latin America. Genes 2019, 10, 153. [Google Scholar] [CrossRef] [PubMed]
- Lo, A.-C.; Kleer, C.G.; Banerjee, M.; Omar, S.; Khaled, H.; Eissa, S.; Hablas, A.; Douglas, J.A.; Alford, S.H.; Merajver, S.D.; et al. Molecular Epidemiologic Features of Inflammatory Breast Cancer: A Comparison between Egyptian and US Patients. Breast Cancer Res. Treat. 2008, 112, 141–147. [Google Scholar] [CrossRef] [PubMed]
- Silverstein, A.; Sood, R.; Costas-Chavarri, A. Breast Cancer in Africa: Limitations and Opportunities for Application of Genomic Medicine. Int. J. Breast Cancer 2016, 2016, 1–4. [Google Scholar] [CrossRef] [PubMed]
- Giordano, S.H.; Hortobagyi, G.N. Inflammatory Breast Cancer: Clinical Progress and the Main Problems That Must Be Addressed. Breast Cancer Res. 2003, 5, 284–288. [Google Scholar] [CrossRef] [PubMed]
- Robertson, F.M.; Bondy, M.; Yang, W.; Yamauchi, H.; Wiggins, S.; Kamrudin, S.; Krishnamurthy, S.; Le-Petross, H.; Bidaut, L.; Player, A.N.; et al. Inflammatory Breast Cancer: The Disease, the Biology, the Treatment. CA Cancer J. Clin. 2010, 60, 351–375. [Google Scholar] [CrossRef] [PubMed]
- Brignoni, L.; Cappetta, M.; Colistro, V.; Sans, M.; Artagaveytia, N.; Bonilla, C.; Bertoni, B. Genomic Diversity in Sporadic Breast Cancer in a Latin American Population. Genes 2020, 11, 1272. [Google Scholar] [CrossRef]
- Adedokun, B.; Zheng, Y.; Ndom, P.; Gakwaya, A.; Makumbi, T.; Zhou, A.Y.; Yoshimatsu, T.F.; Rodriguez, A.; Madduri, R.K.; Foster, I.T.; et al. Prevalence of Inherited Mutations in Breast Cancer Predisposition Genes among Women in Uganda and Cameroon. Cancer Epidemiol. Biomark. Prev. 2020, 29, 359–367. [Google Scholar] [CrossRef]
- Jiagge, E.; Jibril, A.S.; Chitale, D.; Bensenhaver, J.M.; Awuah, B.; Hoenerhoff, M.; Adjei, E.; Bekele, M.; Abebe, E.; Nathanson, S.D.; et al. Comparative Analysis of Breast Cancer Phenotypes in African American, White American, and West Versus East African Patients: Correlation Between African Ancestry and Triple-Negative Breast Cancer. Ann. Surg. Oncol. 2016, 23, 3843–3849. [Google Scholar] [CrossRef]
- Sastry, K.S.; Chouchane, L. Breast Cancer in African Populations. In The Genetics of African Populations in Health and Disease; Ibrahim, M.E., Rotimi, C.N., Eds.; Cambridge University Press: Cambridge, UK, 2019; pp. 199–216. ISBN 978-1-139-68029-5. [Google Scholar]
- Kuribayashi, K.; Krigsfeld, G.; Wang, W.; Xu, J.; Mayes, P.A.; Dicker, D.T.; Wu, G.S.; El-Deiry, W.S. TNFSF10 (TRAIL), a P53 Target Gene That Mediates P53-Dependent Cell Death. Cancer Biol. Ther. 2008, 7, 2034–2038. [Google Scholar] [CrossRef] [PubMed]
- Silva, J.D.D.E.; de Oliveira, R.R.; da Silva, M.T.; Carvalho, M.D.d.B.; Pedroso, R.B.; Pelloso, S.M. Breast Cancer Mortality in Young Women in Brazil. Front. Oncol. 2021, 10, 569933. [Google Scholar] [CrossRef] [PubMed]
- Jia, G.; Ping, J.; Guo, X.; Yang, Y.; Tao, R.; Li, B.; Ambs, S.; Barnard, M.E.; Chen, Y.; Garcia-Closas, M.; et al. Genome-Wide Association Analyses of Breast Cancer in Women of African Ancestry Identify New Susceptibility Loci and Improve Risk Prediction. Nat. Genet. 2024, 56, 819–826. [Google Scholar] [CrossRef] [PubMed]
- Haiman, C.A.; Chen, G.K.; Vachon, C.M.; Canzian, F.; Dunning, A.; Millikan, R.C.; Wang, X.; Ademuyiwa, F.; Ahmed, S.; Ambrosone, C.B.; et al. A Common Variant at the TERT-CLPTM1L Locus Is Associated with Estrogen Receptor-Negative Breast Cancer. Nat. Genet. 2011, 43, 1210–1214. [Google Scholar] [CrossRef] [PubMed]
- Chen, F.; Chen, G.K.; Stram, D.O.; Millikan, R.C.; Ambrosone, C.B.; John, E.M.; Bernstein, L.; Zheng, W.; Palmer, J.R.; Hu, J.J.; et al. A Genome-Wide Association Study of Breast Cancer in Women of African Ancestry. Hum. Genet. 2013, 132, 39–48. [Google Scholar] [CrossRef]
- Adedokun, B.; Du, Z.; Gao, G.; Ahearn, T.U.; Lunetta, K.L.; Zirpoli, G.; Figueroa, J.; John, E.M.; Bernstein, L.; Zheng, W.; et al. Cross-Ancestry GWAS Meta-Analysis Identifies Six Breast Cancer Loci in African and European Ancestry Women. Nat. Commun. 2021, 12, 4198. [Google Scholar] [CrossRef] [PubMed]
- Hoffman, J.; Fejerman, L.; Hu, D.; Huntsman, S.; Li, M.; John, E.M.; Torres-Mejia, G.; Kushi, L.; Ding, Y.C.; Weitzel, J.; et al. Identification of Novel Common Breast Cancer Risk Variants at the 6q25 Locus among Latinas. Breast Cancer Res. 2019, 21, 3. [Google Scholar] [CrossRef]
- Tjader, N.P.; Beer, A.J.; Ramroop, J.; Tai, M.-C.; Ping, J.; Gandhi, T.; Dauch, C.; Neuhausen, S.L.; Ziv, E.; Sotelo, N.; et al. Association of ESR1 Germline Variants with TP53 Somatic Variants in Breast Tumors in a Genome-Wide Study. Cancer Res. Commun. 2024, 4, 1597–1608. [Google Scholar] [CrossRef] [PubMed]
- Gao, G.; Zhao, F.; Ahearn, T.U.; Lunetta, K.L.; Troester, M.A.; Du, Z.; Ogundiran, T.O.; Ojengbede, O.; Blot, W.; Nathanson, K.L.; et al. Polygenic Risk Scores for Prediction of Breast Cancer Risk in Women of African Ancestry: A Cross-Ancestry Approach. Hum. Mol. Genet. 2022, 31, 3133–3143. [Google Scholar] [CrossRef] [PubMed]
- Junior, H.L.R.; Novaes, L.A.C.; Datorre, J.G.; Moreno, D.A.; Reis, R.M. Role of Polygenic Risk Score in Cancer Precision Medicine of Non-European Populations: A Systematic Review. Curr. Oncol. 2022, 29, 5517–5530. [Google Scholar] [CrossRef]
- Hirko, K.A.; Rocque, G.; Reasor, E.; Taye, A.; Daly, A.; Cutress, R.I.; Copson, E.R.; Lee, D.-W.; Lee, K.-H.; Im, S.-A.; et al. The Impact of Race and Ethnicity in Breast Cancer—Disparities and Implications for Precision Oncology. BMC Med. 2022, 20, 72. [Google Scholar] [CrossRef] [PubMed]
- Hipp, L.E.; Hulswit, B.B.; Milliron, K.J. Clinical Tools and Counseling Considerations for Breast Cancer Risk Assessment and Evaluation for Hereditary Cancer Risk. Best Pract. Res. Clin. Obstet. Gynaecol. 2022, 82, 12–29. [Google Scholar] [CrossRef]
- Tyrer, J.; Duffy, S.W.; Cuzick, J. A Breast Cancer Prediction Model Incorporating Familial and Personal Risk Factors. Stat. Med. 2004, 23, 1111–1130. [Google Scholar] [CrossRef] [PubMed]
- Lee, A.; Mavaddat, N.; Wilcox, A.N.; Cunningham, A.P.; Carver, T.; Hartley, S.; Villiers, C.B.d.; Izquierdo, A.; Simard, J.; Schmidt, M.K.; et al. BOADICEA: A Comprehensive Breast Cancer Risk Prediction Model Incorporating Genetic and Nongenetic Risk Factors. Genet. Med. 2019, 21, 1708–1718. [Google Scholar] [CrossRef]
- Carver, T.; Hartley, S.; Lee, A.; Cunningham, A.P.; Archer, S.; Babb de Villiers, C.; Roberts, J.; Ruston, R.; Walter, F.M.; Tischkowitz, M.; et al. CanRisk Tool—A Web Interface for the Prediction of Breast and Ovarian Cancer Risk and the Likelihood of Carrying Genetic Pathogenic Variants. Cancer Epidemiol. Biomark. Prev. 2021, 30, 469–473. [Google Scholar] [CrossRef] [PubMed]
- Lindor, N.M.; Johnson, K.J.; Harvey, H.; Shane Pankratz, V.; Domchek, S.M.; Hunt, K.; Wilson, M.; Cathie Smith, M.; Couch, F. Predicting BRCA1 and BRCA2 Gene Mutation Carriers: Comparison of PENN II Model to Previous Study. Fam. Cancer 2010, 9, 495–502. [Google Scholar] [CrossRef] [PubMed]
- Panchal, S.M.; Ennis, M.; Canon, S.; Bordeleau, L.J. Selecting a BRCA Risk Assessment Model for Use in a Familial Cancer Clinic. BMC Med. Genet. 2008, 9, 116. [Google Scholar] [CrossRef] [PubMed]
- Torkamani, A.; Wineinger, N.E.; Topol, E.J. The Personal and Clinical Utility of Polygenic Risk Scores. Nat. Rev. Genet. 2018, 19, 581–590. [Google Scholar] [CrossRef]
- Osler, T.S.; Schoeman, M.; Pretorius, W.J.S.; Mathew, C.G.; Edge, J.; Urban, M.F. Application of Genetic Testing Criteria for Hereditary Breast Cancer in South Africa. Breast Cancer Res. Treat. 2025. [Google Scholar] [CrossRef]
- Peterson, J.M.; Pepin, A.; Thomas, R.; Biagi, T.; Stark, E.; Sparks, A.D.; Johnson, K.; Kaltman, R. Racial Disparities in Breast Cancer Hereditary Risk Assessment Referrals. J. Genet. Couns. 2020, 29, 587–593. [Google Scholar] [CrossRef] [PubMed]
- Schwartz, C.; Chukwudozie, I.B.; Tejeda, S.; Vijayasiri, G.; Abraham, I.; Remo, M.; Shah, H.A.; Rojas, M.; Carillo, A.; Moreno, L.; et al. Association of Population Screening for Breast Cancer Risk With Use of Mammography Among Women in Medically Underserved Racial and Ethnic Minority Groups. JAMA Netw. Open 2021, 4, e2123751. [Google Scholar] [CrossRef] [PubMed]
BC Subtype | ER Status | PR Status | HER2 Status | Ki67 Level |
---|---|---|---|---|
Luminal A | Positive | Positive/Negative | Negative | Low |
Luminal B | Positive | Positive/Negative | Positive/Negative | High |
HER2 | Negative | Negative | Positive | High |
TNBC | Negative | Negative | Negative | High |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Cupertino, S.E.S.; Gonçalves, A.C.A.; Gusmão Lopes, C.V.; Gradia, D.F.; Beltrame, M.H. The Current State of Breast Cancer Genetics in Populations of African Ancestry. Genes 2025, 16, 199. https://doi.org/10.3390/genes16020199
Cupertino SES, Gonçalves ACA, Gusmão Lopes CV, Gradia DF, Beltrame MH. The Current State of Breast Cancer Genetics in Populations of African Ancestry. Genes. 2025; 16(2):199. https://doi.org/10.3390/genes16020199
Chicago/Turabian StyleCupertino, Sarah Elisabeth Santos, Ana Carolina Aparecida Gonçalves, Claudemira Vieira Gusmão Lopes, Daniela Fiori Gradia, and Marcia Holsbach Beltrame. 2025. "The Current State of Breast Cancer Genetics in Populations of African Ancestry" Genes 16, no. 2: 199. https://doi.org/10.3390/genes16020199
APA StyleCupertino, S. E. S., Gonçalves, A. C. A., Gusmão Lopes, C. V., Gradia, D. F., & Beltrame, M. H. (2025). The Current State of Breast Cancer Genetics in Populations of African Ancestry. Genes, 16(2), 199. https://doi.org/10.3390/genes16020199